Dialysate composition and hemodialysis hypertension

Seminars in Dialysis

Volumn 17, Issue 4, 2004, Pages 279-283

  Flanigan, Michael ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CHLORIDE; NEUROPEPTIDE; SODIUM;

ASTHENIA; BLOOD PRESSURE REGULATION; CHEMICAL COMPOSITION; DIALYSATE; EXTRACELLULAR SPACE; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOTENSION; INTRACELLULAR SPACE; KIDNEY BLOOD FLOW; KIDNEY FAILURE; MUSCLE CRAMP; PATHOPHYSIOLOGY; PRESCRIPTION; PRESSORECEPTOR; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT LOADING; SENSORY NERVE; SODIUM BLOOD LEVEL; SODIUM CHANNEL; SODIUM RESTRICTION; SODIUM TRANSPORT; SYMPTOM; SYSTEMIC VASCULAR RESISTANCE; WEIGHT GAIN;

EXTRACELLULAR FLUID; HEMODIALYSIS SOLUTIONS; HUMANS; HYPERTENSION; RENAL DIALYSIS; SODIUM;

EID: 4243139430     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0894-0959.2004.17327.x     Document Type: Review

References (41)

1. Parsons FM, Stewart WK: The composition of dialysis fluid. In: Drukker WM, Parsons FM, Maher JF (eds). Replacement of Renal Function by Dialysis, 2nd ed. Boston: Martinus-Nijhoff, 1983:148-170
2. Leunissen KM, Hoorntje SJ, Fiers HA, Dekkers WT, Mulder AW: Acetate versus bicarbonate hemodialysis in critically ill patients. Nephron 42:146-151, 1986
3. Huyghebaert MF, Dhainaut JF, Monsallier JF, Schlemmer B: Bicarbonate hemodialysis of patients with acute renal failure and severe sepsis. Crit Care Med 13:840-843, 1985
4. Ronco C, Fabris A, Feriani M: Hemodialysis fluid composition. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF (eds). Replacement of Renal Function by Dialysis, 4th ed. Norwell, MA: Kluwer Academic, 1996:256-276
5. Flanigan MJ, Khairullah QT, Lim VS: Dialysate sodium delivery can alter chronic blood pressure management. Am J Kidney Dis 29:383-391, 1997
6. Song JH, Lee WS, Suh C-K, Kim M-J: Time-averaged concentration of dialysate sodium relates with sodium load and interdialylic weight gain during sodium-profiling hemodialysis. Am J Kidney Dis 40:291-301, 2002
7. Cybulsky AV, Matni A, Hollomby DJ: Effects of high sodium dialysate during maintenance hemodialysis. Nephron 41:57-61, 1985
8. Krautzig S, Janssen U, Koch KM, Granolleras C, Shaldon S: Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 13:552-553, 1998
9. Özkahya M, Ok E, Cirit M, Aydin S, Akcicek F, Basci A, Dorhout Mees EJ: Regression of left ventricular hypertrophy in hemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 13:1489-1493, 1998
10. Kooman JP, Hendriks EJM, van den Sande FM, Leunissen KML: Dialysate sodium concentration and blood pressure control in haemodialysis patients. Nephrol Dial Transplant 15:554-555, 2000
11. Özkahya M, Töz H, Ünsal A, Özerkan F, Asci G, Gürgün C, Akcicek F, Dorhout Mees EJ: Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis 34:218-221, 1999
12. Donohoe P, Farmer C, Dallyn P, Kingswood JC, Goldsmith DJ, Sharpstone P: Low sodium haemodialysis without fluid removal improves blood pressure control in chronic dialysis patients [abstract]. Kidney Int 52:1110, 1997
13. Maduell F, Navarro V: Dietary salt intake and blood pressure control in haemodialysis patients. Nephrol Dial Transplant 15:2063, 2000
14. Maduell F, del Pozo C, Garcia H, Sanchez L, Hdez-Jaras J, Albero MD, Calvo C, Torregrosa I, Navarro V: Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 14:1202-1207, 1999
15. Gotch FA, Lam MA, Prowitt M, Keen M: Preliminary clinical results with sodium-volume modeling of hemodialysis therapy. Proc Clin Dial Transplant Forum 10: 12-17, 1980
16. Petitclere T, Jacobs C: Dialysis sodium concentration: what is optimal and can it be individualized? Nephrol Dial Transplant 10:596-599, 1995
17. Nguyen MK, Kurtz I: Are the total exchangeable sodium, total exchangeable potassium and total body water the only determinants of the plasma water sodium concentration? Nephrol Dial Transplant 18:1266-1271, 2003
18. Campese VM: Neurogenic factors and hypertension in renal disease. Kidney Int 57(suppl 75):S2-S6, 2000
19. Campese V: Role of the sympathetic nervous system in the control of hypertension. Available at http://www.hdcn.com/symp/02asn/cam/cam.htm; visited July 30, 2003
20. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327:1912-1928, 1992
21. Tuncel M, Augustyniak R, Zhang W, Toto RD, Victor RG: Sympathetic nervous system function in renal hypertension. Curr Hypertens Rep 4:229-236, 2002
22. Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG: Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens 20:3-9, 2002
23. Hand MF, Haynes WG, Webb DJ: Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int 3:1068-1077, 1998
24. Hand MF, Haynes WG, Webb DJ: Reduced venous responsiveness to endothelin-1 but not noradrenaline in hypertensive chronic renal failure. Nephrol Dial Transplant 16:295-301, 2001
25. Kopp UC, Matsushita K, Sigmund RD, Smith LA, Watanabe S, Stokes JB: Amiloride-sensitive Na+ channels in pelvic uroepithelium involved in renal sensory receptor activation. Am J Physiol 275(6 pt 2):R1780-R1792, 1998
26. DiBona GF, Kopp UC: Neural control of renal function. Physiol Rev 77:75-197, 1997
27. Widjaja A, Kielstein JT, Horn R, von zur Muhlen A, Kliem V, Brabant G: Free serum leptin but not bound leptin concentrations are elevated in patients with end-stage renal disease. Nephrol Dial Transplant 15:846-850, 2000
28. Mitchell JL, Morgan DA, Correia ML, Mark AL, Sivitz WI, Haynes WG: Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation? Hypertension 38:1081-1086, 2001
29. de Wardener HE: The hypothalamus and hypertension. Physiol Rev 81:1599-1658, 2001
30. Wang H, Leenen FH: Brain sodium channels mediate increases in brain "ouabain" and blood pressure in Dahl S rats. Hypertension 40:96-100, 2002
31. Leenen FH, Ruzicka M, Huang BS: The brain and salt-sensitive hypertension. Curr Hypertens Rep 4:129-135, 2002
32. Huang BS, Leenen FH: Brain amiloride-sensitive Phe-Met-Arg-Phe-NH(2)- gated Na(+) channels and Na(+)-induced sympathoexcitation and hypertension. Hypertension 39(2 pt 2):557-561, 2002
33. DiBona GF: Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 11:197-200, 2002
34. Huang BS, Wang H, Leenen FH: Enhanced sympathoexcitatory and pressor responses to central Na+ in Dahl salt-sensitive vs. -resistant rats. Am J Physiol 281:H1881-H1889, 2001
35. Snyder PM: The epithelial Na+ channel cell surface insertion and retrieval in Na+ homeostasis and hypertension. Endocr Rev 23:258-275, 2002
36. Matsuoka H, Kimura G, Sanai T, Kojima S, Kawano Y, Imanishi M, Kuramochi M, Omae T: Normalization of increased sodium sensitivity by maintenance hemodialysis. Am J Hypertens 3(8 pt 1):628-631, 1990
37. DiBona GF: Peripheral and central interactions between the renin-angiotensin system and the renal sympathetic nerves in control of renal function. Ann N Y Acad Sci 940:395-406, 2001
38. Sang GL, Kovithavongs C, Ulan R, Kjellstrand CM: Sodium ramping in hemodialysis: a study of beneficial and adverse effects. Am J Kidney Dis 29:669-677, 1997
39. Petitclerc T: Estimation of mass transfer through a hemodialyzer: theoretical approach and clinical applications. Artif Organs 22:601-607, 1998
40. Krzesinski JMF, Rorive G: Intracellular cation concentrations in essential hypertension and chronic renal failure. Clin Exp Hypertens 15:461-478, 1993
41. DiBona GF: Central angiotensin modulation of baroreflex control of renal sympathetic nerve activity in the rat: influence of dietary sodium. Acta Physiol Scand 177:285-289, 2003